A PHASE-II STUDY OF CPT-11 (IRINOTECAN 350 MG M(2) EVERY 3 WEEKS) IN UNTREATED NON-SMALL-CELL LUNG CARCINOMAS/

Citation
Jy. Douillard et al., A PHASE-II STUDY OF CPT-11 (IRINOTECAN 350 MG M(2) EVERY 3 WEEKS) IN UNTREATED NON-SMALL-CELL LUNG CARCINOMAS/, European journal of cancer, 31A, 1995, pp. 1095-1095
Citations number
NO
Categorie Soggetti
Oncology
Journal title
ISSN journal
09598049
Volume
31A
Year of publication
1995
Supplement
5
Pages
1095 - 1095
Database
ISI
SICI code
0959-8049(1995)31A:<1095:APSOC(>2.0.ZU;2-0